Market closed

Precigen/PGEN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Precigen

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Ticker

PGEN
Trading on

Industry

Biotechnology

Employees

202

Precigen Metrics

BasicAdvanced
$259M
Market cap
-
P/E ratio
-$0.54
EPS
1.72
Beta
-
Dividend rate
$259M
1.72
$1.93
$0.82
824K
1.03
0.881
11.749
14.688
-7,919.33%
-42.32%
-129.32%
51.141
5.26
17.25
-2.88
-80.14%
-639.53%
-55.61%
-2.76%

What the Analysts think about Precigen

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Precigen stock.

Precigen Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Precigen Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy PGEN

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Precigen stock?

Precigen (PGEN) has a market cap of $259M as of October 12, 2024.

What is the P/E ratio for Precigen stock?

The price to earnings (P/E) ratio for Precigen (PGEN) stock is 0 as of October 12, 2024.

Does Precigen stock pay dividends?

No, Precigen (PGEN) stock does not pay dividends to its shareholders as of October 12, 2024.

When is the next Precigen dividend payment date?

Precigen (PGEN) stock does not pay dividends to its shareholders.

What is the beta indicator for Precigen?

Precigen (PGEN) has a beta rating of 1.72. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.